Mechanism of sulfur mustard induced lung injury
芥子气致肺损伤的机制
基本信息
- 批准号:7727021
- 负责人:
- 金额:$ 31.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AbscessAcetylcholineAcetylcholinesteraseAcuteAddressAirway ResistanceAlkylating AgentsAllergensAmbrosiaAnimal ExperimentsAnimalsAnti-CholinergicsAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAntidotesAntigensAntioxidantsApoptosisApoptoticAsthmaAtropineAttenuatedAutoantigensAutoimmune ProcessAutoimmune ResponsesAutoimmunityB-LymphocytesBasal CellBindingBiologicalBiological AssayBody TemperatureBreathingBronchial SpasmBronchiectasisBronchoalveolar LavageBronchoalveolar Lavage FluidBronchoconstrictionBullaCCL2 geneCD8B1 geneCategoriesCell DeathCell membraneCell surfaceCellsCessation of lifeChemical AgentsChemical WeaponsCholinergic AgentsChronicChronic BronchitisCollaborationsCombined Modality TherapyConditionCorrosivesCoughingCytotoxic T-LymphocytesDataDepthDermalDevelopmentDiagnosticDinitrochlorobenzeneDiseaseDoseEMSAEarly InterventionEnd PointEnzyme-Linked Immunosorbent AssayEpinephrineEpithelialExhibitsExperimental DesignsExposure toExtrinsic asthmaEyeFK506FeverFutureHealth PersonnelHealth Services ResearchHistopathologyHourHumanHydralazineImmigrationImmune responseImmunityImmunohistochemistryImmunosuppressionImmunosuppressive AgentsImplantIn VitroInfiltrationInflammationInflammatoryInjuryInterleukin-13InterventionIranIraqKineticsLactate DehydrogenaseLactate DehydrogenasesLeukocytesLeukopeniaLeukotrienesLiquid substanceLungLung InflammationLupusLymphocyteMajor Histocompatibility ComplexMeasuresMembrane ProteinsMethodsMitogen-Activated Protein Kinase InhibitorMitogen-Activated Protein KinasesModelingModificationMuscarinic Acetylcholine ReceptorMuscarinic AntagonistsMustard GasNatural ImmunityNecrosisNeurotransmittersNuclearPainPathologyPathway interactionsPatientsPenicillin GPharmaceutical PreparationsPharyngeal structurePhysical condensationPlethysmographyPneumoniaPopulationPost-Translational Protein ProcessingProbabilityProcainamideProcessProductionPropertyProteinsPublishingPulmonary FibrosisRattusRattus norvegicusReactionRecurrenceReportingReverse Transcriptase Polymerase Chain ReactionRiskRoleSignal TransductionSiteSkinSmall Inducible Cytokine A3Smooth MuscleSoldierSpectrophotometrySpleenSteroidsStressStructure of parenchyma of lungSulfamethoxazoleSulfidesSymptomsSynapsesSyndromeT-LymphocyteTerrorismTestingTherapeutic AgentsTherapeutic InterventionTherapeutic immunosuppressionTimeTissuesToxic Epidermal NecrolysisToxic effectTreatment ProtocolsTurpentineVeteransWarWeekWestern BlottingWorkWorld War Iairway hyperresponsivenessairway inflammationatopybasechemokinecholinergiccytokinedesigndirect applicationhuman MAPK14 proteinimprovedin vivoindexinginhibitor/antagonistlung injurymacrophagemigrationneutrophiloutcome forecastresearch studyrespiratoryresponsestemtranscription factor
项目摘要
Sulfur mustard (SM) is a powerful alkylating agent that was used extensively during the World War I and in
1980s' Iran-Iraq war, and analysts in the CIA, DOD, and the Congressional Research Service (CRS) have
ranked SM as the highest probability agent to be used as a chemical weapon for terrorism. While exposure to
high doses of SM may be lethal, sublethal exposures cause serious acute and chronic injuries primarily to the
lung, skin and eyes and, to date, there is no effective treatment against SM. The respiratory consequences of
acute SM exposure include throat pain, cough, and asthma-like symptoms, such as tachypnea,
bronchospasms, and airway hyperresponsiveness, and the delayed effects, which might arise after months to
years after SM exposure, comprise chronic bronchitis, asthma, bronchiectasis, and pulmonary fibrosis.
Because the mechanism of SM-induced lung injury is not clear, it is a major hurdle in the development of
rationale therapeutic interventions. Based on the published data, we propose that the lung injury associated
with SM exposure results from its two properties: (a) SM is an extremely powerful alkylating agent that
rapidly modifies cellular proteins, and we hypothesize that the major biological effects stem from the
immunological consequences of these modifications. The early effects emerge from the activation of
innate immunity (inflammation) and the associated cell death, and the delayed effects from the
activation of the adaptive immune response directed to the modified (alkylated) self-antigens, leading
to a chronic autoimmune status, (b) SM inhibits acetylcholinesterase that raises the synaptic level of
acetylcholine causing acute bronchoconstriction, bronchospasms, and exacerbated asthma.
Therefore, a combination of anti-inflammatory, immunosuppressive, anti-apoptotic, and anti-cholinergic drugs
administered immediately after SM exposure might ameliorate both the early and the late respiratory effects of
SM toxicity. To address the working hypothesis, we propose to: (1) evaluate the role of inflammation in SMinduced
lung injury, (2), examine the effects of acute SM inhalation on airway resistance, (3) ascertain the
effects of SM exposure on the development of adaptive immunity, and (4) examine the effects of potential
therapeutic agents (particularly combination therapies) on the acute and chronic toxicities of SM exposure.
These studies, we believe, will delineate the mechanism(s) of acute and chronic respiratory effects of SM
exposure and provide a rationale approach to design and test the efficacy of therapeutic interventions.
硫芥末(SM)是一种强大的烷基化剂,在第一次世界大战期间广泛使用
1980年代的伊朗 - 伊拉克战争,以及中央情报局,国防部和国会研究服务局(CRS)的分析师
将SM排名为最高的概率,被用作恐怖主义的化学武器。在暴露时
高剂量的SM可能是致命的,可杀死的暴露主要导致严重的急性和慢性伤害
肺,皮肤和眼睛,迄今为止,还没有有效的SM治疗方法。呼吸后果
急性SM暴露包括喉咙痛,咳嗽和类似哮喘的症状,例如tachypnea,
支气管播和气道高反应性以及延迟的效果,几个月后可能会出现
SM暴露几年后,包括慢性支气管炎,哮喘,支气管扩张和肺纤维化。
因为SM诱导的肺损伤的机制尚不清楚,所以这是发展的主要障碍
理由治疗干预措施。根据已发布的数据,我们建议肺部损伤与
SM暴露的两种特性导致:(a)SM是一种极强大的烷基化剂,
快速修饰细胞蛋白,我们假设主要的生物学作用源于
这些修饰的免疫学后果。早期效应来自激活
先天免疫(炎症)和相关的细胞死亡,以及延迟的影响
针对修饰(烷基化)自我抗原的自适应免疫反应的激活,领先
至慢性自身免疫性状态,(b)SM抑制乙酰胆碱酯酶提高突触水平
乙酰胆碱导致急性支气管收缩,支气管施加和恶化的哮喘。
因此,抗炎,免疫抑制,抗凋亡和抗胆碱能药物的结合
SM暴露后立即给药可能会改善早期和晚期呼吸作用
SM毒性。为了解决工作假设,我们提出:(1)评估炎症在示威中的作用
肺损伤(2)检查急性SM吸入对气道电阻的影响,(3)确定
SM暴露对自适应免疫发展的影响,(4)检查潜力的影响
SM暴露的急性和慢性毒性上的治疗剂(尤其是联合疗法)。
我们认为,这些研究将描述SM的急性和慢性呼吸作用的机制
暴露并提供一种理由方法来设计和测试治疗干预措施的功效。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Neerad Mishra其他文献
Neerad Mishra的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Neerad Mishra', 18)}}的其他基金
HIV-associated Chronic Obstructive Pulmonary Disease
HIV 相关的慢性阻塞性肺疾病
- 批准号:
8927053 - 财政年份:2014
- 资助金额:
$ 31.18万 - 项目类别:
HIV-associated Chronic Obstructive Pulmonary Disease
HIV 相关的慢性阻塞性肺疾病
- 批准号:
9100911 - 财政年份:2014
- 资助金额:
$ 31.18万 - 项目类别:
HIV-associated Chronic Obstructive Pulmonary Disease
HIV 相关的慢性阻塞性肺疾病
- 批准号:
8847549 - 财政年份:2014
- 资助金额:
$ 31.18万 - 项目类别:
HIV-associated Chronic Obstructive Pulmonary Disease
HIV 相关的慢性阻塞性肺疾病
- 批准号:
9302513 - 财政年份:2014
- 资助金额:
$ 31.18万 - 项目类别:
相似国自然基金
伪旋毛虫乙酰胆碱酯酶破坏肠道ILC2s的ChAT-ACh通路实现免疫逃逸的机制研究
- 批准号:32302960
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
元宝枫种子中抑制乙酰胆碱酯酶活性成分的高效发现及其作用机理研究
- 批准号:32100323
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
元宝枫种子中抑制乙酰胆碱酯酶活性成分的高效发现及其作用机理研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠神经元芳香烃受体/乙酰胆碱酯酶信号通路介导的青黛肠道不良反应研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
具有乙酰胆碱酯酶抑制活性间苯三酚衍生物的发现及其作用机制研究
- 批准号:
- 批准年份:2019
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
A Vitamin K analog countermeasure for organophosphate poisoning
维生素 K 类似物治疗有机磷中毒的对策
- 批准号:
10602913 - 财政年份:2023
- 资助金额:
$ 31.18万 - 项目类别:
Targeting Cholinergic Deficits with Retinoic Acid after TBI
使用视黄酸治疗 TBI 后的胆碱能缺陷
- 批准号:
10741924 - 财政年份:2023
- 资助金额:
$ 31.18万 - 项目类别:
Uncharted Territory: Mapping and Manipulating Cholinergic Basal Forebrain Activity in a Mouse Model of Alzheimer's Disease
未知领域:绘制和操纵阿尔茨海默病小鼠模型中的胆碱能基础前脑活动
- 批准号:
10537906 - 财政年份:2023
- 资助金额:
$ 31.18万 - 项目类别:
Novel oxime antidotes for an organophosphate insecticide requiring bioactivation
用于需要生物活化的有机磷杀虫剂的新型肟解毒剂
- 批准号:
10629574 - 财政年份:2023
- 资助金额:
$ 31.18万 - 项目类别:
Impact of chronic alcohol on neuronal cholinergic signaling
慢性酒精对神经元胆碱能信号的影响
- 批准号:
10667844 - 财政年份:2023
- 资助金额:
$ 31.18万 - 项目类别: